FDA — authorised 7 July 1958
- Marketing authorisation holder: CARACO
- Status: approved
🇺🇸 Synalgos-Dc in United States
FDA authorised Synalgos-Dc on 7 July 1958
Marketing authorisations
FDA — authorised 7 July 1958
- Application: NDA011483
- Marketing authorisation holder: SUN PHARM INDUSTRIES
- Local brand name: SYNALGOS-DC
- Indication: CAPSULE — ORAL
- Status: approved
Synalgos-Dc in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in United States
Frequently asked questions
Is Synalgos-Dc approved in United States?
Yes. FDA authorised it on 7 July 1958; FDA authorised it on 7 July 1958.
Who is the marketing authorisation holder for Synalgos-Dc in United States?
CARACO holds the US marketing authorisation.